Gabriel Souza-Silva

Dr. Gabriel Souza-Silva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
GSGabriel Souza-Silva
Gabriel Souza-Silva
CSClessius Ribeiro de Souza
Clessius Ribeiro de Souza
CPCíntia Aparecida de Jesus Pereira
Cíntia Aparecida de Jesus Pereira
WLWalter dos Santos Lima
Walter dos Santos Lima
MMMarcos Paulo Gomes Mol
Marcos Paulo Gomes Mol
MSMicheline Rosa Silveira
Micheline Rosa Silveira

29 May 2023 in Science of The Total Environment
Verified
Journal Article
Closed access
GSGabriel Souza-Silva
Gabriel Souza-Silva
CSClessius Ribeiro Souza
Clessius Ribeiro Souza
CPCíntia Aparecida de Jesus Pereira
Cíntia Aparecida de Jesus Pereira
WLWalter dos Santos Lima
Walter dos Santos Lima
MMMarcos Paulo Gomes Mol
Marcos Paulo Gomes Mol
MSMicheline Rosa Silveira
Micheline Rosa Silveira

10 October 2024 in Toxics
Verified
Journal Article
Open access
PDF file
SSSandra Regina Silva
Sandra Regina Silva
GSGabriel Souza-Silva
Gabriel Souza-Silva
CMCarolina Paula de Souza Moreira
Carolina Paula de Souza Moreira
OVOlívia Maria de Sousa Ribeiro Vasconcelos
Olívia Maria de Sousa Ribeiro Vasconcelos
MSMicheline Rosa Silveira
Micheline Rosa Silveira
MMMarcos Mol
Marcos Mol
Tenofovir disoproxil fumarate (TDF) is an antiretroviral drug extensively used by people living with HIV. The TDF molecule is hydrolysed in vivo and liberates tenofovir, the active part of the molecule. Tenofovir is a very stable drug and the discharge of its residues into the environment can potentially lead to risk for aquatic species. This study evaluated the TDF biodegradation and removal by cultures of Microcystis novacekii with the bacteria Pseudomonas pseudoalcaligenes. Concentrations of TDF of 12.5, 25.0, and 50.0 mg/L were used in this study. The process occurred in two stages. In the first 72 h, TDF was de-esterified, forming the tenofovir monoester intermediate by abiotic and enzymatic processes associated in an extracellular medium. In a second step, the monoester was removed from the culture medium by intracellular processes. The tenofovir or other by-products of TDF were not observed in the test conditions. At the end of the experiment, 88.7 to 94.1% of TDF and its monoester derivative were removed from the culture medium over 16 days. This process showed higher efficiency of TDF removal at the concentration of 25 mg/L. Tenofovir isoproxil monoester has partial antiviral activity and has shown to be persistent, maintaining a residual concentration after 16 days in the culture medium, therefore indicating the need to continue research on methods for total removal of this product from the aquatic environment.

12 March 2025 in Water
Verified
Journal Article
Open access
PDF file
GSGabriel Souza-Silva
Gabriel Souza-Silva
MMMariângela Domingos Alcântara Mari
Mariângela Domingos Alcântara Mari
CSCléssius Ribeiro de Souza
Cléssius Ribeiro de Souza
CMCarolina Paula de Souza Moreira
Carolina Paula de Souza Moreira
KNKenia Pedrosa Nunes
Kenia Pedrosa Nunes
MSMicheline Rosa Silveira
Micheline Rosa Silveira
Antiretrovirals (ARVs) have become one of the most prescribed groups of drugs, and these residues are found in the environment. Among them, the most widely used in HIV treatment are tenofovir (TDF), lamivudine (3TC), and dolutegravir (DTG). This study aimed to evaluate the toxicity of ARVs TDF, 3TC, and DTG on the cyanobacterium Microcystis novacekii and estimate their environmental risk. DTG showed the highest toxicity among the drugs tested, inhibiting cyanobacteria cell growth and metabolic activity at low concentrations. TDF and 3TC alone were less toxic, with more pronounced adverse effects in long time exposures at high concentrations. However, the combination of ARVs, especially TDF and 3TC, showed a synergistic effect, significantly increasing toxicity compared to the drugs alone. Excipients found in commercial formulations of ARVs, such as sodium lauryl sulfate, also influenced toxicity. Although DTG showed the highest risk to cyanobacteria, the environmental risk assessment indicated that TDF and 3TC, although less toxic to M. novacekii, may pose moderate-to-high environmental risks at typical environmental concentrations. These results reinforce the need for strict regulation and monitoring of the release of ARVs into the environment, and the development of effective treatments for removing these residues in sewage treatment plants. This study contributes to understanding the ecotoxicological impacts of ARVs and highlights the importance of long-term assessments to adequately estimate the environmental risks of ARVs and their commercial formulations.

16 October 2025 in Environments
Verified
Journal Article
Open access
PDF file
GSGabriel Souza-Silva
Gabriel Souza-Silva
VBValéria Aparecida Bispo
Valéria Aparecida Bispo
MMMariângela Domingos Alcântara Mari
Mariângela Domingos Alcântara Mari
MSMaria Clara Starling
Maria Clara Starling
CSCléssius Ribeiro de Souza
Cléssius Ribeiro de Souza
MSMicheline Rosa Silveira
Micheline Rosa Silveira
Antiretrovirals (ARVs) present variable toxicity to aquatic organisms. This study reviewed the literature from the Web of Science, Scopus, and PubMed to evaluate ARV ecotoxicity, focusing on aquatic models. Inclusion criteria were studies using ARVs as test substances with toxicity data on aquatic organisms. Quality assessment followed the CRED method, and environmental risk was evaluated via risk quotients (RQs) using the ERA tool. Efavirenz emerged as the most toxic ARV, with EC50 values of 0.011 mg/L (Chlorococcum infusionum) to 0.034 mg/L (Raphidocelis subcapitata), causing growth inhibition, photosynthesis reduction, and oxidative stress. Tenofovir showed lower toxicity, with EC50 values above 300.0 mg/L (Biomphalaria glabrata) and 111.82 mg/L (Artemia salina). Other ARVs, including Lamivudine and Zidovudine, displayed moderate toxicity (EC50 3.013–5.442 mg/L in microalgae). Main effects observed included oxidative damage, altered enzyme activity (catalase and NADH-cytochrome C oxidoreductase), reduced growth and photosynthesis, and bioaccumulation in aquatic plants like Lemna minor. Efavirenz also showed synergistic toxicity when combined with other ARVs. These findings indicate that ARVs, particularly highly toxic compounds such as Efavirenz, pose significant ecological risks, emphasizing the importance of proper disposal and remediation strategies to protect aquatic ecosystems.

12 June 2020 in Journal of Public Health
Verified
Journal Article
Closed access
GSGabriel Souza-Silva
Gabriel Souza-Silva
MMMarcos Mol
Marcos Mol
Background: Waste pickers are considered a vulnerable population at risk for potential health damage. Taking into account the risk of hepatitis B or C infection in this population, the aim of this study was to show the prevalence of these diseases in waste pickers from South America, through a systematic review. Methods: The search covered publications until February 2020, accessed through Google Scholar database. Epidemiological studies on hepatitis B or C focused on waste pickers in South America were included. All selected papers were evaluated for quality. Results: Six studies composed this systematic review, all conducted in Brazil and using cross-sectional study. The prevalence of all makers (HBsAg or anti-HBc) for hepatitis B varied from 4.3 to 33.4% while for hepatitis C varied from 1.6 to 12.4%. Conclusion: The lack of results showed the requirement for more research about hepatitis including this informal workers group. High prevalences of hepatitis B and C in waste pickers highlighted the need of increase preventive health protection as vaccination against hepatitis B; training on working conditions; and the use of individual protection.